Immune response and gene polymorphism profiles in Crohn's disease and ulcerative colitis

Inflammatory Bowel Diseases

Volumn 15, Issue 3, 2009, Pages 353-358

  Magalhäes Queiroz, Dulciene Maria ^a   Gonçalves Oliveira, Adriana ^a   Saraiva, Ivan Euclides Borges ^a   Rocha, Gifone Aguiar ^a   Rocha, Andreia Maria Camargos ^a   Pimenta Sanna, Maria das Graças ^a   Guerra, Juliana Becattini ^a   Dani, Renato ^a   Abreu Ferrari, Maria de Lourdes ^a   Fonseca Castro, Lúcia Porto ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

IL 1; IL 2; Inflammatory bowel disease; NOD2 CARD15; TNF; Toll like receptor

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; MEMBRANE PROTEIN; PROTEIN TNFA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; DNA; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NOD2 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BRAZIL; CONFOUNDING VARIABLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ULCERATIVE COLITIS; VARIABLE NUMBER OF TANDEM REPEAT; CELLULAR IMMUNITY; COMPARATIVE STUDY; FOLLOW UP; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOTYPE; IMMUNOLOGY; METABOLISM; PREVALENCE; RETROSPECTIVE STUDY;

ADULT; ALLELES; BRAZIL; COLITIS, ULCERATIVE; CROHN DISEASE; DNA; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LINKAGE DISEQUILIBRIUM; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 66149101005     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20757     Document Type: Article

References (41)

1. Rogler G. Update in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol. 2004;20:311-317.
2. Balfour Sartor R. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastroenterol. 2003; 19:358-365.
3. Watts DA, Satsangi J. The genetic jigsaw of inflammatory bowel disease. Gut. 2002;50:31-36.
4. Eckmann L. Innate immunity and mucosal bacterial interactions in the intestine. Curr Opin Gastroenterol. 2004;20:82-88.
5. Podolsky DK. Inflammatory Bowel Disease. N Engl J Med. 2002;347: 417-429.
6. Watanabe T, Kitani A, Murray PJ, et al. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity. 2006;25:473-485.
7. Leung E, Hong J, Fraser AG, et al. Polymorphisms of CARD15/NOD2 and CD14 genes in New Zealand Crohn's disease patients. Immunol Cell Biol. 2005;83:498-503.
8. Heliö T, Halme L, Lappalainen M, et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut. 2003;52:558-562.
9. Halfvarson J, Bresso F, D'Amato M, et al. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins. Dig Liver Dis. 2005;37:768-772.
10. Özen SC, Da&gcaron;li Ü, Kiliç MY, et al. NOD2/ CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. J Gastroenterol. 2006; 41:304-310.
11. Leong RWL, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther. 2003;17:1465-1470.
12. Francimont D, Vermeire S, El Housni H, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut. 2004;53:987-992.
13. Brand S, Staudinger T, Schnitzler F, et al. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis. 2005;11:645-652.
14. Gazouki M, Mantzaris G, Kotsinas A, et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol. 2005;11:681-685.
15. Braat HM, Stokkers P, Hommes T, et al. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J Mol Med. 2005;83:601-609.
16. Netea MG, Kullberg BJ, de Jong DJ et al. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol. 2004; 34:2052-2059.
17. Watanabe T, Kitani A, Murray PJ, et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol. 2004;5:800-808.
18. Pierik M, Joosens S, Van Steen K, et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis. 2006;12:1-8.
19. Allen RD. Polymorphisms of the human TNF-alpha promoter - random variation or functional diversity? Mol Immunol. 1999;36:1017-1027.
20. Vatay A, Bene L, Kovacs A et al. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics. 2003;55:247-252.
21. Yamamoto-Furusho JK. Immunogenetics of chronic ulcerative colitis. Rev Invest Clin. 2003;55:705-710.
22. Zipperlen K, Peddle L, Melay B, et al. Association of TNF-alpha polymorphisms in Crohn's disease. Hum Immunol. 2005;66:56-59.
23. Gonzalez S, Rodrigo L, Martinez-Borra J, et al. TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol. 2003;98:1101-1106.
24. Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic associations between ulcerative colitis and the anti-inflammatory cytokine interleukin- 1 receptor antagonist. Gastroenterology. 1994;106:637-642.
25. Heresbach D, Alizadeh M, Dabadie A, et al. Significance of interleukin- 1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol. 1997; 92:1164-1169.
26. Vijgen L, Van Gysel M, Rector A, et al. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease. Genes Immun. 2002;3:400-406.
27. Stokkers PCF, Van Aken BE, Basoski N, et al. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut. 1998;43:33-39.
28. Gonzalez Sarmiento R, Araoz P, Rodriguez R, et al. Polymorphism of the IL1RN gene in Spanish patients with ulcerative colitis. Med Clin (Barc). 1999;112:778-779.
29. Matesanz F, Fedetz M, Leyva L, et al. Effects of multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression. J Neuroimmunol. 2004;148:212-217.
30. Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol. 2006;24:657-679.
31. Baumgart DC, Olivier WA, Reya T, et al. Mechanisms of intestinal epithelial cell injury and colitis in interleukin 2 (IL2)-deficient mice. Cell Immunol. 1998;187:52-66.
32. Ferguson A, Ghosh S, Harny LM, et al. Analysis of disease distribution, activity and complications in the patient with inflammatory bowel disease. Scand J Gastroenterol. 1994;203(suppl):15-19.
33. Parra FC, Amado RC, Lambertucci JR, et al. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A. 2003;100:177-182.
34. Hamajima N, Matsuo K, Saito T, et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res. 2001;92:383-389.
35. Togawa S, Joh T, Itoh M, et al. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter. 2005;10:172-178.
36. Sánchez E, Orozco G, López-Nevot MA, et al. Polymorphisms of Toll-like receptor 2 and 4 in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens. 2004;63:54-57.
37. Michel O, Levan TD, Stern D, et al. Systemic responsiveness to lipopolysaccharide and polymorphisms in the Toll-like receptor 4 gene in human beings. J Allergy Clin Immunol. 2003;112:923-929.
38. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley Interscience Publication; 2000.
39. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study if heritability and the influence of smoking. Gut. 1988;29:990-996.
40. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911-920.
41. Rocha GA, Guerra JB, Rocha AMC, et al. IL1RN polymorphic gene and cagA-positive status independently increase the risk of noncardia gastri carcinoma. Int J Cancer. 2005;115:678-683.